-
1 Comment
PKU HealthCare Corp.,Ltd is currently in a long term uptrend where the price is trading 6.6% above its 200 day moving average.
From a valuation standpoint, the stock is 80.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.9.
PKU HealthCare Corp.,Ltd's total revenue sank by 9.5% to $565M since the same quarter in the previous year.
Its net income has increased by 8.2% to $16M since the same quarter in the previous year.
Finally, its free cash flow grew by 65.1% to $-14M since the same quarter in the previous year.
Based on the above factors, PKU HealthCare Corp.,Ltd gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers - Specialty & Generic |
| Exchange | SHE |
| CurrencyCode | CNY |
| ISIN | CNE0000008M0 |
| Beta | 0.29 |
|---|---|
| Market Cap | 3B |
| PE Ratio | 24.43 |
| Target Price | None |
| Dividend Yield | 1.3% |
PKU HealthCare Corp.,Ltd. researches, develops, manufactures, and sells pharmaceutical products in China. It offers products in various categories, including anti-tumor, psychoneurological, cardiovascular, immunosuppressive, antimicrobial, antipyretic and analgesic, digestive system, regulate immunity, oncology, anti-allergic, blood sugar regulation, mental disorder, and blood volume expansion. The company was formerly known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. and changed its name to PKU HealthCare Corp., Ltd. in November 2013. The company was founded in 1965 and is headquartered in Chongqing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 000788.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
